Open Label, Randomized Multicentric Phase II Clinical Trial of Mycobacterium w in Combination With Paclitaxel Plus Cisplatin Versus Paclitaxel and Cisplatin in Advanced Non Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 01 Feb 2017
At a glance
- Drugs Cadi 05 (Primary) ; Cisplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Cadila Pharmaceuticals
- 06 Aug 2012 Additional lead trial investigators added as reported by ClinicalTrials.gov.
- 15 Feb 2012 Planned number of patients changed from 220 to 221 as reported by Clinical Trials Registry - India record.
- 15 Feb 2012 Status changed from active, no longer recruiting to completed as reported by Clinical Trials Registry - India record.